Allena Pharmaceuticals to Present at the 2014 J.P. Morgan Healthcare Conference
NEWTON, Mass., January 13, 2014 –Allena Pharmaceuticals, a life sciences company focused on developing and commercializing a non-systemic protein therapeutics to treat metabolic and orphan diseases, with a focus on nephrologic and urologic conditions, announced today that Alexey Margolin Ph.D., President and Chief Executive Officer of Allena, will present at the J.P. Morgan Healthcare Conference on Wednesday, January 15 at 11:00 a.m. Pacific Standard Time at the Westin St. Francis in San Francisco.
About Allena Pharmaceuticals
Allena Pharmaceuticals is developing and commercializing non-systemic protein therapeutics to treat metabolic and orphan diseases, with a particular focus on nephrologic and urologic conditions.
Allena was founded in 2011 with $15 million in Series A venture capital financing led by top-tier venture investors Bessemer Venture Partners, Frazier Healthcare and Third Rock V entures.
Based in Newton, Mass., Allena was co-founded by Alexey Margolin, Ph.D., and Robert Gallotto, industry leaders with a proven track record of success in protein therapeutic design and development. Allena is leveraging its leadership team’s combined operational expertise in manufacturing, formulation and non-systemic protein delivery.